Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Research Use Only: This product is intended exclusively for laboratory research and development
Slowly direct the solvent down the inside wall of the vial rather than injecting directly onto the powder
Missing detailssuch as failing to identify the joint or omitting the type of medication injectedare among the most common causes of payer denials
pathway enrichment analysis revealed enriched features associated with amino acid, sphingolipid, and glycerophospholipid metabolism in CAR T cell products following rapamycin treatment (Fig
What FDA has said recently (high-level, patient-friendly summary) FDA maintains a page describing certain bulk drug substances used in compounding that may present significant safety risks, including AOD-9604, noting concerns such as potential immunogenicity and limited safety-related information for some uses/routes
